Everything’s Coming Up Pfizer: The Biggest Of Pharma Firms Leads Industry In Pending Applications For US FDA Approval

Pfizer’s lineup of novel agents under review stands at seven, while no other big pharma has more than two novel candidates; Sanofi is tops in recent approvals since 2021, with seven novel agents cleared, but has no pending NMEs.

review roses
• Source: Shutterstock

Pfizer Inc. has laid the groundwork to continue its reign as the biggest of the big pharma companies with the industry’s largest array of new drug and biologic applications for US FDA approval. Seven novel agents from Pfizer are currently under review, according to the Pink Sheet’s US FDA Performance Tracker.

Pfizer and BioNTech SE’s COVID-19 vaccine Comirnaty is responsible in no small part for the company’s seat at the top of the Scrip 100 rankings by global pharmaceutical sales,...

More from US FDA Performance Tracker

More from Regulatory Trackers